Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

NCT01617954 is registered in ClinicalTrials.gov with Agendia as lead sponsor.

NCT NCT01617954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01617954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
Lead sponsor
Agendia
Phase
Observational
Overall status
Completed
Start date
May 31, 2012
Completion date
December 31, 2015
Enrollment
820 (actual)
Sites
53

Conditions

As the registry lists them; a condition with its own page is linked.

hormone receptor positive malignant neoplasm of breast